Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The European neurovascular device market will grow strongly through 2027, fueled by rapid expansion of the neurovascular thrombectomy device market and by the uptake of newer neurovascular intervention technologies.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurovascular devices in Europe across a 10-year period.
The positive results of the DAWN trial have extended the treatment window for AIS events.
How will the extended treatment window of a stroke event impact neurovascular thrombectomy procedure volumes?
How do the AIS treatment landscapes differ between European countries?
Many competitors are entering the neurovascular thrombectomy device market in Europe.
How will new products impact the neurovascular thrombectomy device market?
What challenges will new companies encounter in this space? Will they capture significant share from existing competitors?
The flow-diverting device market is seeing strong growth.
How will adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?
How has the competitive landscape changed with the emergence of new competitors and products?
The initial results of the HEAT trial demonstrated the superiority of hydrogel-coated embolization coils in comparison to bare platinum coils
How dramatically will these results impact the use of coated and bare platinum coils? What role will cost play in device uptake?
Which companies will benefit from these favorable results, and which companies will be negatively impacted?
Already a Client? Log in to access this report.
Shruthi Narendranath is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in heart valve and periphral vascular device markets. Shruthi holds a Master's degree in Bioinformatics from Cardiff University.